Recently, a judge in Federal District Court in Manhattan ruled that Myriad’s patents on BRCA1 and BRCA2 genes were invalid, being a “products of the law nature” and could be patented no more than, say, mount Everest. These two genes are associated with breast and ovarian cancer, and are used in testing for susceptibility to […]
AMOS is a suite of genome assembly and editing software. It includes assemblers, validation, visualization, and scaffolding tools. I have been having some issues installing AMOS on Ubuntu 9.10. Specifically, Ubuntu 9.10 has gcc 4.4, which breaks the compilation of the AMOS release version. However, the development version has been fixed to accommodate that. If […]
Pawel on Open Science. Full disclosure: I consider sharing an office with this guy for over a year to be one of the best experiences of my postdoc.
Yes! Why should the evolution people have all the fun with their blog carnival? (After all, it is only a theory.) It’s time for bioinformaticians to show what we are made of, and to have a carnival of our own. Bio::blogs had a good run some time ago. I decided to reconnect what is hopefully […]
Byte Size Biology will be hosting the first edition of the bioinformatics blog carnival. All you bioinformatics bloggers, submit your entries by Mar 9, 2010 23:59:03 EST. Note the 3 second extension I have already given. There will be no more deadline extensions, I’ve been generous enough as it is. The carnival will be posted […]
As part of the process of manufacturing a new car, the designers will take the blueprints to the factory floor. There they will set up an experimental assembly line, tinkering with the manufacturing process of the prototype until it is ready for mass-production. Can we do the same with the machinery of life — the assembly […]
Seriously, this is what I first thought when I saw the cover of this week’s Nature, and the associated drawings in the press. The dude’s haircut seems like it was even bad in the ’80s… 2080 BCE that is, which is when his body is dated. Approximately. A large group of researchers were involved in […]
If the title of this post makes you cringe, then you belong to a minority of people who realize why the phrase “highly evolved” is so wrong. Unfortunately, “highly evolved” (as an absolute term) and “more evolved” (as a comparative term) seem to be used all-too frequently. They are uttered not only by non-scientists and […]
In celebration of the biohackathon happening now in Tokyo, I am putting up a script that is oddly missing from many bioinformatic packages: extracting intergenic regions. This one was written together with my student, Ian. As for the biohackathon itself, I’m not there, but I am following the tweets and Brad Chapman’s excellent posts: Day […]
A small spike on my blog traffic yesterday led me to look for the source via Google Analytics. (If you are a blogger, you should really use this tool, lots of useful traffic information.) Seems like most of the traffic came from the page of a high school science teacher at Badin High School in […]
Pharmaceutical companies are always on the lookout for secondary drug targets. After all, if you invest billions developing a single drug, you would be more than happy to sell it as a treatment for two, three, or more different ailments. Sildenafil citrate was developed to treat angina and hypertension, but during phase I clinical trials, […]
Seems like I had a couple of taxonomic posts recently. So BsB would like to know what is your favorite Kingdom of life. I used the 6 kingdom system just to make things slightly more interesting. Vote in the pollbox on the righthand sidebar. You only have yourself to blame if your favorite kingdom is […]
